Allergy & Immunology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX ® in House Dust Mite Allergic Rhinitis
Conditions: Allergic Rhinitis Due to House Dust Mite; Allergic Asthma Interventions: Drug: Standardised allergen extract from house dust mites Sponsors: ALK-Abell ó A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Testing a Barbershop-based HIV Prevention Initiative Among Men
Conditions: HIV Infections Interventions: Behavioral: General, status-neutral HIV education; Diagnostic Test: HIV self-test kits; Other: Information about where to receive HIV prevention services; Behavioral: Barber-led peer support group education; Behavioral: Facility-based HIV risk reduction counseling; Diagnostic Test: Facility-based HIV testing; Other: Information about facility distributed HIV self-test kits; Diagnostic Test: STI testing Sponsors: HIV Prevention Trials Network; Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); National Instit...
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials

Safety Study of SLV213 for the Treatment of COVID-19.
Conditions: COVID-19 Interventions: Other: Placebo for SLV213; Drug: SLV213 Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

To Develop an Algorithm for Predicting the Unfavorable Course of Sepsis in Children Based on a Comprehensive Assessment of Immunological, Biochemical and Molecular Genetic Markers
Conditions: Sepsis Interventions: Diagnostic Test: flow cytometry; Diagnostic Test: ELISA; Diagnostic Test: RFLP Sponsors: The Republican Research and Practical Center for Epidemiology and Microbiology; Belarusian State Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials

The IBD-FITT study — moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial
DiscussionThis will be a clinical trial investigating the effect of exercise on patients with Crohn ’s disease and ulcerative colitis. This trial will add to the evidence on the possible effect of exercise and might clarify whether exercise can benefit as a supplementary treatment addendum. Thus, the trial may provide a new patient-active disease management approach.Trial registrationClinicalTrials.gov NCT04816812. Date of first registration: March 23, 2021. (Source: Trials)
Source: Trials - November 20, 2023 Category: Research Source Type: clinical trials

Group CBT in Parents of Children With Food Allergy
Conditions: Parents Interventions: Behavioral: CBT Sponsors: University of Missouri, Kansas City Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

The ARHINASD (Allergic Rhinitis in Pediatric Subjects With Nasal Septum Deviation) Project
Conditions: Rhinitis, Allergic Interventions: Other: Data collection Sponsors: Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Immunoblot, Chemiluminescence and ImmunoCap Allergen Specific IgE Evaluation of in Allergic Rhinitis Patients
Conditions: Diagnoses Disease Interventions: Diagnostic Test: Sensitization to House dust mites Sponsors: Zagazig University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Conditions: ITP - Immune Thrombocytopenia Interventions: Drug: eltrombopag and romiplastim Sponsors: Assiut University; Association for Training, Education, and Research in Hematology, Immunology, and Transplantation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials

Investigation of the Frequency of Hereditary Hyper Alpha-tryptasemia in Patients With Elevated Basal Tryptasemia
Conditions: Allergic Bronchiolitis Interventions: Genetic: Serum Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Hypoallergenicity of a New Formula in Subjects With Cow's Milk Allergy
Conditions: Allergy; Cow ' s Milk Allergy Interventions: Dietary Supplement: Liquid Extensively hydrolyzed cow ' s milk protein infant formula Sponsors: Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Conditions: Mpox Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; National Institute of Allergy and Infectious Diseases (NIAID); Leidos Biomedical Research, Inc.; Alliance for International Medical Action; University of California, Los Angeles; Institut de Recherche pour le Developpement; University of Manito ba Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Conditions: Carcinoma; Intrahepatic Cholangiocarcinoma; Gallbladder Cancer; Surufatinib; Angiogenesis Inhibitors; Tislelizumab; Antineoplastic Agents, Immunological; Immunotherapy Interventions: Drug: HAIC; Drug: Surufatinib; Drug: Tislelizumab Sponsors: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Protocol CAUSE-03 / CHEETAH
Conditions: Asthma Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Analysis of Cellular Kinases and Aging in PBMCs and Colorectal Tissue
Conditions: HIV Infections; Aging Interventions: Other: biopsy Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials